Please choose your application, enter the information requested below. * Marked fields are mandatory.
Product Description
GDC-0927 (SRN-927) is a novel, potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist.
IC50 & Target: Estrogen receptor[1]
In Vivo: GDC-0927 is a novel, potent, non-steroidal, orally bioavailable, selective ER antagonist/ER degrader (SERD) that induces tumor regression in estrogen receptor (ER)+breast cancer (BC) patient-derived xenograft models[1].
Information
CAS No1642297-01-5
FormulaC28H28FNO4
Clinical Informationclinicalinformation
PathwayOthers
TargetEstrogen Receptor/ERR
Specifications
Purity / Grade>98%
Solubility10 mM in DMSO
Smilessmiles
Misc Information
Alternative NamesSRN-927
Observed Molecular Weight461.52
related data
Get valuable resources and offers directly to your email.
